Home >> Industry News >> Illumina receives EUA for sequencing-based COVID-19 dx

Illumina receives EUA for sequencing-based COVID-19 dx

image_pdfCreate PDF

The workflow accommodates up to 3,072 samples per NovaSeq run, leveraging the S4 flow cell, and includes steps for viral RNA extraction, RNA-to-CDNA conversion, PCR, library preparation, sequencing, and report generation. Components include the NovaSeq 6000 coupled with Illumina Tagmentation library preparation technology and the Dragen COVIDSeq Test Pipeline for rapid reporting.

COVIDSeq is available to a limited number of early access sites, the company reports, and is expected to be more broadly available this summer.

CAP TODAY
X